Bedoelde u
medicines use

Zoekresultaten - 4 results

Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.

estimate incidence, describe clinical presentation and investigate factors associated with severe outcomes using multivariable analysis. RESULTS: Up to December 31, 2020, 26 countries reported information on ...

Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.

people with CF  (pwCF). METHODS: We used the 38-country European Cystic Fibrosis Society Patient Registry (ECFSPR) to collect case data about pwCF and SARS-CoV-2 infection. RESULTS: Up to 30 June 2020, 16 ...

Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis.

different patient subgroups. Multivariable logistic regression models were used to analyse the association between cancer and clinical characteristics (baseline analysis) and the effect of cancer on ...

Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.

regression was used to investigate factors associated with clinical progression to severe COVID-19, using the primary outcome of hospitalisation with supplemental oxygen. RESULTS: SARS-CoV-2 was reported in ...

QR code

QR code for this page URL